With AI-related cryptocurrencies gaining momentum, several projects have seen increased market activity and user adoption.

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Skyward Specialty also announced the following fourth quarter 2024 preliminary results and provided 2025 guidance: Highlights for the fourth quarter included: Gross written premiums of $388.4 million, ...

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of "aa-" (Superior ...

Houston-headquartered Skyward Specialty Insurance Group Inc has commuted a loss portfolio transfer and adverse development ...

Skyward Specialty Insurance Group, Inc. has commuted the Loss Portfolio Transfer and Adverse Development and Retrocession ...

MIAMI--(BUSINESS WIRE)--LPT is proud to announce that Mercedes Saewitz, a highly accomplished real estate professional with over 20 years of experience, has joined the company as Senior Vice ...

The Company received $11.7 million in cash. Additionally, at December 31, 2024 the Company strengthened LPT loss reserves by $25.3 million and recognized approximately $9.8 million, net of tax ...

This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for ...